Skip to main content

Research

Research grants

Pharmacologic strategies to use the levonorgestrel implant in HIV-infected women

NATIONAL INSTITUTES OF HEALTH (USA)

December 2015 - November 2020

Protease inhibitors and drug disposition (PROCOM/FORTE Trial)

MEDICAL RESEARCH COUNCIL

October 1997 - December 2003

Pharmacogenetic and pharmacokinetic studies.

MONUMENT TRUST (UK)

August 2005 - April 2011

Modelling adherence, pharmacokinetics and treatment outcomes in HIV therapy.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

September 2003 - September 2008

Therapeutic Drug Monitoring of Anti-HIV Drugs.

MONUMENT TRUST (UK)

October 1999 - September 2003

Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults.

JOINT CLINICAL RESEARCH CENTRE (UGANDA)

September 2010 - December 2012

Effects within HAART on markers of adipose function.

PENNINE ACUTE HOSPITALS NHS TRUST (UK)

December 2005 - June 2009

The pharmacology of HIV treatment failure.

BRITISH SOCIETY FOR ANTIMICROBIAL CHEMOTHERAPY (UK)

October 2001 - December 2008

Effects of NRTIs on adipose function.

PENNINE ACUTE HOSPITALS NHS TRUST (UK)

January 2006 - June 2009

TAILoR (TelmisArtan and InsuLin Resistance in HIV): A dose-ranging Phase II randomised open trial of telmistartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on Combination Antiretroviral Therapy (CART)

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

January 2012 - February 2020

A pharmacokinetic evaluation of levonorgestrel implant and antiretroviral therapy.

NATIONAL INSTITUTES OF HEALTH (USA)

November 2013 - December 2016

Modulation of TB-HIV drug interaction by host genetic influences

MEDICAL RESEARCH COUNCIL

July 2010 - June 2013

Sub contractual agreement for multiple plasma sample tests agreement

ST STEPHEN'S AIDS TRUST (UK)

August 2009 - July 2012

Population pharmacokinetic-pharmacodynamic modelling to optimise treatments for HIV,TB and malaria

WELLCOME TRUST (UK)

November 2008 - October 2012

Detection of minority strains of HIV harbouring drug resistance.

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

October 2002 - September 2005

Therapeutic Drug Monitoring for HIV Protease Inhibitors.

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

February 2000 - January 2003

Influx and efflux transporters: a possible pharmacological determinant of HIV treatment failure.

AVERT (UK)

September 2000 - August 2003

Understanding cellular resistance - an important link to understanding virological resistance.

AVERT (UK)

September 2001 - August 2004

Assessment of TMC-278LA

MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION (MWRIF) (USA)

January 2012 - March 2017

Liverpool Oxford Tropical Link (LOTLINK) in Clinical Pharmacology.

WELLCOME TRUST (UK)

January 2002 - December 2006

A real time polymerase chain reaction machine and technical support.

MONUMENT TRUST (UK)

December 2003 - July 2006

The Use of 'virtual' Inhibitory Quotients to Optimise HIV Treatment.

DEPARTMENT OF HEALTH & SOCIAL CARE (UK)

January 2003 - December 2009

St Stephens Aids Trust - SSAT trials

ST STEPHEN'S AIDS TRUST (UK)

April 2010 - March 2020

HIV Research Trust Award for M Lamorde

HIV RESEARCH TRUST (UK)

May 2009 - July 2009

Evaluation of the steady state pharmakinectics of second line antiretroviral drugs when administered under different meal conditions in HIV-infected Ugandan adults

INFECTIOUS DISEASES INSTITUTE (UGANDA)

September 2010 - December 2011

Bioanalytical facility for drugs and small molecules

ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST (UK)

July 2010 - June 2011